377 related articles for article (PubMed ID: 16741314)
21. Initial Evaluation of (99m)Tc(CO)3(ASMA) as a Renal Tracer in Healthy Human Volunteers.
Lipowska M; Klenc J; Folks RD; Taylor AT
Nucl Med Mol Imaging; 2014 Sep; 48(3):216-24. PubMed ID: 25177379
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m ethylene dicysteine: a new renal tubular function agent.
Kabasakal L
Eur J Nucl Med; 2000 Mar; 27(3):351-7. PubMed ID: 10774890
[TBL] [Abstract][Full Text] [Related]
23. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
24. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties.
Boschi A; Uccelli L; Bolzati C; Duatti A; Sabba N; Moretti E; Di Domenico G; Zavattini G; Refosco F; Giganti M
J Nucl Med; 2003 May; 44(5):806-14. PubMed ID: 12732683
[TBL] [Abstract][Full Text] [Related]
27. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
28. Rhenium analogues of promising renal imaging agents with a [99mTc(CO)3]+ core bound to cysteine-derived dipeptides, including lanthionine.
He H; Lipowska M; Xu X; Taylor AT; Marzilli LG
Inorg Chem; 2007 Apr; 46(8):3385-94. PubMed ID: 17375908
[TBL] [Abstract][Full Text] [Related]
29. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
30. The value of different washout parameters in the evaluation of renal transplants by technetium-99m-ethylene- l-l-dicysteine.
Kanmaz B; Sayman HB; Alan N; Devranoglu G; Nisli S; Sonmezoglu K; Kabasakal L; Halac M; Onsel C; Uslu I
Hell J Nucl Med; 2010; 13(2):127-31. PubMed ID: 20808985
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of novel cationic 99mTc(I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging.
He Z; Hsieh WY; Kim YS; Liu S
Nucl Med Biol; 2006 Nov; 33(8):1045-53. PubMed ID: 17127179
[TBL] [Abstract][Full Text] [Related]
32. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
Trejtnar F; Laznicek M; Laznickova A
Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
[TBL] [Abstract][Full Text] [Related]
33. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
Eshima D; Taylor A
Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
[TBL] [Abstract][Full Text] [Related]
37. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
[TBL] [Abstract][Full Text] [Related]
38. Clearance and renal extraction of technetium-99m-L,L-ethylenedicysteine, I-131-ortho-iodohippurate and I-125-iothalamate in pigs.
Nielsen SS; Poulsen EU; Marqversen J; Nielsen LE; Bacher T; Rehling M
Clin Physiol; 1999 Jul; 19(4):338-43. PubMed ID: 10451795
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
Taylor A; Eshima D; Christian PE; Milton W
Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
[TBL] [Abstract][Full Text] [Related]
40. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
Schibli R; La Bella R; Alberto R; Garcia-Garayoa E; Ortner K; Abram U; Schubiger PA
Bioconjug Chem; 2000; 11(3):345-51. PubMed ID: 10821650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
